← Screener

RMD ResMed Inc.

Healthcare

Price
$220.77
Intrinsic value
$136.72
Buy price
$109.38
Discount
-61.5%
Overvalued

DCF walkthrough

Near-term growth (g1)12.88%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
Operating CF
$1,889,964,000.00
Total debt
$825,918,976.00
Cash & STI
$1,469,234,048.00
Shares out.
144,976,000
Overvalued
Intrinsic value$136.74
Buy price (with MOS)$109.39
Current price$220.77
Discount to intrinsic value-61.5%

7-step quality scorecard

ROE quality
HIGH_CONSISTENT
Average ROE
22.3%
Current ROE
23.5%
Minimum ROE
21.0%
Debt quality
CONSERVATIVE
Debt / Equity
0.14x
Moat proxy
STRONG_PROXY
Cash-flow reliability
OK
Operating CF / Net income
1.24x

Technical chart

Confluence: DOWNTREND (2/3)

Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim.

Assumptions & data quality

Data source
yfinance
Growth (g1) source
revenueCAGR
Valuation model
DCF_OCF
Debt as % of DCF PV
4.3%
Public economic interest
100.0%

These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.